Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea
- 19 January 2010
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 54 (7) , 991-1003
- https://doi.org/10.1002/mnfr.200900218
Abstract
Several medicinal plants that stimulate glucose uptake in skeletal muscle cells were identified from among species used by the Cree of Eeyou Istchee of northern Quebec to treat symptoms of diabetes. This study aimed to elucidate the mechanism of action of one of these products, the berries of Vaccinium vitis idaea, as well as to isolate and identify its active constituents using a classical bioassay‐guided fractionation approach. Western immunoblot analysis in C2C12 muscle cells revealed that the ethanol extract of the berries stimulated the insulin‐independent AMP‐activated protein kinase (AMPK) pathway. The extract mildly inhibited ADP‐stimulated oxygen consumption in isolated mitochondria, an effect consistent with metabolic stress and the ensuing stimulation of AMPK. This mechanism is highly analogous to that of Metformin. Fractionation guided by glucose uptake activity resulted in the isolation of ten compounds. The two most active, quercetin‐3‐O‐glycosides, enhanced glucose uptake by 38–59% (50 μM; 18 h treatment) in the absence of insulin. Quercetin aglycone, a minor constituent, stimulated uptake by 37%. The quercetin glycosides and the aglycone stimulated the AMPK pathway at concentrations of 25–100 μM, but only the aglycone inhibited ATP synthase in isolated mitochondria (by 34 and 79% at 25 and 100 μM, respectively). This discrepancy suggests that the activity of the glycosides may require hydrolysis to the aglycone form. These findings indicate that quercetin and quercetin 3‐O‐glycosides are responsible for the antidiabetic activity of V. vitis crude berry extract mediated by AMPK. These common plant products may thus have potential applications for the prevention and treatment of insulin resistance and other metabolic diseases.Keywords
This publication has 43 references indexed in Scilit:
- Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part IICanadian Journal of Physiology and Pharmacology, 2009
- Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in miceBritish Journal of Pharmacology, 2008
- Medicinal plants of Cree communities (Québec, Canada): antioxidant activity of plants used to treat type 2 diabetes symptomsThis article is one of a selection of papers published in this special issue (part 2 of 2) on the Safety and Efficacy of Natural Health Products.Canadian Journal of Physiology and Pharmacology, 2007
- Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5′-AMP-activated Protein KinaseJournal of Biological Chemistry, 2007
- Mechanism of inhibition of bovine F 1 -ATPase by resveratrol and related polyphenolsProceedings of the National Academy of Sciences, 2007
- CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cellsBiochemical and Biophysical Research Communications, 2007
- The role of AMP‐activated protein kinase in mitochondrial biogenesisThe Journal of Physiology, 2006
- Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disordersThe Journal of Physiology, 2006
- Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinasePublished by Elsevier ,2005
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001